Arnhold LLC’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.93M | Hold |
12,636
| – | – | 0.14% | 71 |
|
|
2025
Q4 | $1.74M | Hold |
12,636
| – | – | 0.13% | 74 |
|
|
2025
Q3 | $1.62M | Hold |
12,636
| – | – | 0.14% | 70 |
|
|
2025
Q2 | $1.53M | Hold |
12,636
| – | – | 0.14% | 71 |
|
|
2025
Q1 | $1.41M | Hold |
12,636
| – | – | 0.14% | 63 |
|
|
2024
Q4 | $1.23M | Hold |
12,636
| – | – | 0.12% | 70 |
|
|
2024
Q3 | $1.45M | Hold |
12,636
| – | – | 0.14% | 63 |
|
|
2024
Q2 | $1.35M | Hold |
12,636
| – | – | 0.14% | 61 |
|
|
2024
Q1 | $1.22M | Hold |
12,636
| – | – | 0.13% | 66 |
|
|
2023
Q4 | $1.28M | Hold |
12,636
| – | – | 0.14% | 66 |
|
|
2023
Q3 | $1.29M | Hold |
12,636
| – | – | 0.15% | 69 |
|
|
2023
Q2 | $1.28M | Hold |
12,636
| – | – | 0.14% | 75 |
|
|
2023
Q1 | $1.16M | Sell |
12,636
-3,000
| -19% | -$262K | 0.13% | 79 |
|
|
2022
Q4 | $1.42M | Hold |
15,636
| – | – | 0.17% | 72 |
|
|
2022
Q3 | $1.19M | Hold |
15,636
| – | – | 0.16% | 77 |
|
|
2022
Q2 | $1.32M | Hold |
15,636
| – | – | 0.16% | 72 |
|
|
2022
Q1 | $1.37M | Buy |
15,636
+3,000
| +24% | +$260K | 0.15% | 69 |
|
|
2021
Q4 | $1.1M | Sell |
12,636
-3,000
| -19% | -$249K | 0.13% | 78 |
|
|
2021
Q3 | $1.28M | Hold |
15,636
| – | – | 0.15% | 69 |
|
|
2021
Q2 | $1.43M | Hold |
15,636
| – | – | 0.16% | 66 |
|
|
2021
Q1 | $1.34M | Sell |
15,636
-212
| -1% | -$19K | 0.16% | 72 |
|
|
2020
Q4 | $1.5M | Hold |
15,848
| – | – | 0.19% | 69 |
|
|
2020
Q3 | $1.38M | Hold |
15,848
| – | – | 0.2% | 64 |
|
|
2020
Q2 | $1.38M | Hold |
15,848
| – | – | 0.22% | 63 |
|
|
2020
Q1 | $1.31M | Hold |
15,848
| – | – | 0.24% | 62 |
|
|
2019
Q4 | $1.5M | Hold |
15,848
| – | – | 0.24% | 70 |
|
|
2019
Q3 | $1.38M | Hold |
15,848
| – | – | 0.23% | 74 |
|
|
2019
Q2 | $1.45M | Sell |
15,848
-1,838
| -10% | -$156K | 0.25% | 73 |
|
|
2019
Q1 | $1.52M | Hold |
17,686
| – | – | 0.27% | 68 |
|
|
2018
Q4 | $1.36M | Hold |
17,686
| – | – | 0.25% | 75 |
|
|
2018
Q3 | $1.36M | Hold |
17,686
| – | – | 0.24% | 80 |
|
|
2018
Q2 | $1.2M | Hold |
17,686
| – | – | 0.21% | 90 |
|
|
2018
Q1 | $1.28M | Buy |
+17,686
| New | +$1.35M | 0.24% | 85 |
|
Other funds holding NVS
Arnhold LLC's NVS Position: Q1 2026 in Review
Arnhold LLC held its Novartis (NVS) position steady in Q1 2026 at 12,636 shares worth $1.93M. The position accounts for 0.14% of the portfolio, ranked #71.
Arnhold LLC first reported a position in NVS in Q1 2018 and has held it in 33 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Arnhold LLC held 12,636 shares of Novartis worth $1.93M as of Q1 2026.
- Arnhold LLC left its Novartis share count unchanged in Q1 2026.
- Novartis made up 0.14% of Arnhold LLC's portfolio in Q1 2026, its #71 holding.
- Arnhold LLC first reported a position in Novartis in Q1 2018 and has held it in 33 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Arnhold LLC's 13F filing for Q1 2026, filed 11 May 2026.